Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
McGuff Pharmaceuticals
McGuff Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ascor
Ascorbic acid
2017-10-02
2024-2033
Common cold
,
Constipation
,
Methemoglobinemia
,
Penetrating wounds
,
Tyrosinemias
,
Scurvy
,
Hypercholesterolemia
,
Hypophosphatemia
,
Hypertriglyceridemia
,
Peripheral vascular diseases
,
Dermatitis
,
Alcoholic neuropathy
,
Seizures
,
Vitamin a deficiency
,
Hypoparathyroidism
,
Inborn errors metabolism
,
Photosensitivity disorders
,
Thiamine deficiency
,
Folic acid deficiency
,
Rickets
,
Vitamin b 6 deficiency
,
Megaloblastic anemia
,
Vitamin b deficiency
,
Xerophthalmia
,
Wernicke encephalopathy
,
Beriberi
,
Night blindness
,
Riboflavin deficiency
,
Pellagra
,
Chronic kidney failure
,
Cardiovascular diseases
,
Psoriasis
,
Lung neoplasms
,
Crohn disease
,
Skin neoplasms
,
Familial hypophosphatemic rickets
,
Osteoporosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ascorbic acid
keratoconjunctivitis sicca
,
dry eye syndromes
,
healthy volunteers/patients
,
diabetic retinopathy
,
pigmentation
Aglatimagene besadenovec
breast neoplasms
,
ovarian neoplasms
,
renal cell carcinoma
,
colorectal neoplasms
,
pancreatic neoplasms
,
melanoma
,
liver neoplasms
,
squamous cell neoplasms
,
mesothelioma
,
follicular lymphoma
,
small cell lung carcinoma
,
triple negative breast neoplasms
,
neoplasms
,
adenocarcinoma
,
squamous cell carcinoma of head and neck
,
prostatectomy
,
castration-resistant prostatic neoplasms
,
recurrence
,
prostatic neoplasms
,
prostatic hyperplasia
,
urinary bladder neck obstruction
,
disease progression
,
neoplasm metastasis
,
erectile dysfunction
,
hypertension
,
diabetes mellitus
,
motor activity
,
coronary artery disease
,
hypersensitivity
Bevifimod
phenylketonurias
Retinol
melanoma
,
carcinoma
,
neoplasms
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
lung neoplasms
,
respiratory tract diseases
,
germ cell and embryonal neoplasms
,
small cell lung carcinoma
,
lung diseases
,
respiratory tract neoplasms
,
bronchogenic carcinoma
,
thoracic neoplasms
,
adenocarcinoma
,
bronchial diseases
,
neoplasms by histologic type
,
neoplasms by site
,
nerve tissue neoplasms
,
osteoporosis
,
postmenopausal osteoporosis
,
chronic renal insufficiency
,
vitamin d deficiency
,
renal insufficiency
,
kidney transplantation
,
anemia
Taxane
renal cell carcinoma
,
colorectal neoplasms
,
esophageal squamous cell carcinoma
,
anaplastic thyroid carcinoma
,
disease progression
,
hematologic neoplasms
,
neoplasms
,
pancreatic neoplasms
,
pancreatic ductal carcinoma
,
head and neck neoplasms
,
castration-resistant prostatic neoplasms
,
squamous cell carcinoma
,
adenocarcinoma
,
stomach neoplasms
,
urologic neoplasms
,
transitional cell carcinoma
,
sarcoma
,
recurrence
,
squamous cell carcinoma of head and neck
,
invasive hydatidiform mole
,
melanoma
,
urinary bladder neoplasms
,
hemangiosarcoma
,
squamous cell neoplasms
,
breast neoplasms
,
prostatic neoplasms
,
non-small-cell lung carcinoma
,
neoplasm metastasis
,
ovarian neoplasms
,
carcinoma
,
triple negative breast neoplasms
,
adenocarcinoma of lung
,
brain neoplasms
,
osteitis deformans
,
hereditary sensory and autonomic neuropathies
,
fallopian tube neoplasms
,
peritoneal neoplasms
,
lobular carcinoma
,
ductal carcinoma breast
,
lung neoplasms
,
neuroendocrine tumors
,
large cell carcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use